neuroblastoma
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
neuroblastoma
Jul 26, 2024, 03:16 |
Blog
Ruzanna Papyan: Educational Session at the Global Neuroblastoma Network
Ruzanna Papyan shared a post on LinkedIn: "Dear Friends and Colleagues, We are thrilled to…
Jul 24, 2024, 13:28 |
Blog
Ruzanna Papyan: The significant role of anti-GD2 therapy in the treatment of relapsed or refractory neuroblastoma
Ruzanna Papyan shared a post on LinkedIn about a recent paper by Patricia Raiser et al., commenting:…
Jul 17, 2024, 02:54 |
Blog
Ruzanna Papyan was awarded the prestigious SIOP Young Investigator Award - Pediatric Cancer and Blood Disorders Center of Armenia
Pediatric Cancer and Blood Disorders Center of Armenia shared a post on LinkedIn: “We are…
Jul 15, 2024, 12:05 |
Blog
Ruzanna Papyan: Our abstract on Anti-GD2 for Neuroblastoma will be an oral presentation at SIOP
Ruzanna Papyan shared on LinkedIn: "Week 4 of the Global Access To Anti GD2 Campaign This…
Jul 11, 2024, 15:54 |
Positive
Mark Butler will provide funding for interim access to a new treatment for high-risk Neuroblastoma
Lucy Jones, CEO at Neuroblastoma Australia, shared on LinkedIn: "Delighted to share the news that…
Jul 4, 2024, 14:08 |
Insight
Giselle Sholler: So proud of our Penn State Pediatric Oncology Research Interns for 2024
Giselle Sholler, Division Chief of Pediatric Hematology and Oncology at Penn State Health Children’s Hospital,…
Jul 1, 2024, 00:19 |
Blog
Late Effects After High-Risk Neuroblastoma - St. Baldrick's Foundation
St. Baldrick's Foundation shared on LinkedIn: "Modern therapies (such as stem cell transplant and immune…
Jun 29, 2024, 17:42 |
Blog
Fantastic updates about treating intermediate-risk neuroblastoma - St. Baldrick’s Foundation
St. Baldrick’s Foundation shared a post on LinkedIn: Exciting Update on Neuroblastoma Treatment! Researchers involved in…
Jun 28, 2024, 15:39 |
Blog
Gevorg Tamamyan: Everyone involved in pediatric oncology needs to be part of our global movement of conquering childhood cancer with SIOP
Gevorg Tamamyan shared on LinkedIn: “The wonderful trip to Japan is coming to its end!…
Jun 22, 2024, 16:56 |
Insight
WEHI launches Ternax focused on neuroblastoma and prostrate cancer - Children's Cancer Institute
Children's Cancer Institute shared on LinkedIn: “We send our heartfelt congratulations to WEHI (Walter and…
Jun 22, 2024, 08:34 |
Insight
Major Advancement in Neuroblastoma Research by Keck School of Medicine - The Babak Lab
Maria Babak shared a post by The Babak Lab on LinkedIn, adding: “This is inspiring news…
Jun 2, 2024, 10:24 |
Blog
Lucy Jones: As childhood cancers are rare, the only way to drive research is with the support of the community
Lucy Jones, CEO at Neuroblastoma Australia, shared a post by Neuroblastoma Australia on LinkedIn, adding:…
May 27, 2024, 12:01 |
Drugs
Ruzanna Papyan: I suggest delving into the critical management of adverse events associated with dinutuximab beta
Ruzanna Papyan shared on LinkedIn: "Week 3 of the Global Access To Anti GD2 Campaign:…
May 20, 2024, 11:34 |
Blog
Maite Gorostegui: Our recent article about finding a better way to tolerate and infuse antiGD2 immunotherapy
Maite Gorostegui, Chair of the SIOP Global Mapping Programme, shared a post on LinkedIn: "Our…
May 16, 2024, 08:20 |
Cancer Types
Neuroblastoma: What patients should know about
What is Neuroblastoma? Neuroblastoma is a type of cancer that originates in early nerve cells,…
May 13, 2024, 14:53 |
Blog
Ruzanna Papyan: The life-saving potential of anti-GD2 therapy in treating high-risk neuroblastoma
Ruzanna Papyan shared the following on LinkedIn: ''Week 2 of the Global Access To AntiGD2…
May 13, 2024, 13:41 |
Insight
Innovative stem cell model provides insight into childhood cancer origins
Researchers from the University of Sheffield and St. Anna Children’s Cancer Research Institute have created…
May 11, 2024, 13:13 |
Insight
6th Emirate's Pediatric Hematology and Oncology Conference in Abu Dhabi - Barcelona Children's Hospital Sant Joan de Déu
Barcelona Children's Hospital Sant Joan de Déu shared on LinkedIn: “Last weekend, our hospital took…
May 2, 2024, 23:31 |
Blog
Ruzanna Papyan: Week 1 of Global Access To AntiGD2 Campaign
Ruzanna Papyan, Pediatric Oncologist at Pediatric Cancer and Blood Disorders Center of Armenia, shared the…
Apr 26, 2024, 12:05 |
Blog
The final day of GIORNATE AIEOP 2024!
AIEOP: Italian Association of Pediatric Hematology and Oncology shared on LinkedIn: "That concludes the final…
Apr 24, 2024, 22:17 |
Drugs
Giselle Sholler: Exciting to see Norgine moving forward with seeking approval for DFMO internationally
Giselle Sholler, Division Chief, Pediatric Hematology and Oncology at Penn State Health Children’s Hospital, shared…
Apr 21, 2024, 17:14 |
Blog
Francesca Del Bufalo: It is a huge responsibility and I will do my best to do more and more for fighting neuroblastoma
Francesca Del Bufalo, Pediatric Haematology-Oncology Consultant at Bambino Gesù Chidren’s Hospital, shared on Linkedin: "I…
Apr 18, 2024, 13:30 |
Blog
Salma El Menawi: Exciting Study on Bilateral Adrenal Neuroblastoma in Pediatric Patients
Salma El Menawi, Clinical Research Senior Supervisor at Children's Cancer Hospital Foundation, shared on LinkedIn: "Exciting…
Apr 11, 2024, 14:40 |
Insight
Simone Cesaro: The graft versus neuroblastoma effect
Simone Cesaro, Director Pediatric Hematology Oncology Unit at Integrated University Hospital of Verona, posted on…
Mar 31, 2024, 14:23 |
Blog
Dana-Farber Cancer Institute: Five Dana-Farber scientists have been chosen to receive Wong Family Awards in Translational Oncology for fiscal year 2024
Dana-Farber Cancer Institute posted on LinkedIn: "Five Dana-Farber scientists have been chosen to receive Wong…
Mar 15, 2024, 15:29 |
Insight
Pablo Berlanga Charriel: The French real-world experience on chemo-immunotherapy in patients with relapsed/progressive high-risk neuroblastoma
Pablo Berlanga Charriel, Pediatric Oncology Consultant at Gustave Roussy, posted on LinkedIn: "I am very…
Mar 13, 2024, 16:26 |
Blog
Shushan Hovsepyan: Does the choice of chemotherapy regimen make a difference in relapse/progressive high-risk neuroblastoma?
Shushan Hovsepyan, Pediatric Oncologist and Clinical Research Coordinator at the Yeolyan Hematology and Oncology Center,…
Mar 5, 2024, 15:38 |
Insight
Australian researchers are looking to nanotechnology for a new approach to treating children with cancer - Children's Cancer Institute
Children's Cancer Institute shared a post on LinkedIn: "Australian researchers are looking to nanotechnology for…
Mar 3, 2024, 02:21 |
Blog
Tracey O’Brien: Beautifully told story of two hero’s in childhood cancer as told by Paolo Carniel
Tracey O’Brien shared on LinkedIn a post by Paolo Carniel, Manager Strategic Projects at The…
Feb 4, 2024, 23:00 |
Blog
Charting the Future of Neuroblastoma Treatment at SIOPEN Meeting - St. Anna Children's Cancer Research Institute
St. Anna Children's Cancer Research Institute made the following post on LinkedIn: "Charting the Future…
Jan 21, 2024, 07:44 |
Blog
Cristina Larrosa: We recently mapped anti-GD2 mAbs availability worldwide
Cristina Larrosa, Pediatric Oncologist at Sant Joan de Déu Barcelona Hospital, recently posted on LinkedIn:…
Jan 16, 2024, 17:21 |
Insight
Jan Molenaar: Our study on single-cell analysis of Neuroblastoma tumors
Guillermo Chantada, President of SIOP, shared a LinkedIn post by Jan Molenaar, Principal Investigator at…
Jan 12, 2024, 16:41 |
Insight
A detailed 'atlas' of neuroblastoma tumors points to a new target for immunotherapy - Prinses Máxima Centrum voor kinderoncologie
Quoting Prinses Máxima Centrum voor kinderoncologie on LinkedIn: "A detailed 'atlas' of neuroblastoma tumors points…
Jan 7, 2024, 04:24 |
Stories
Ryan Brown: Cocktails for a Cure - Supporting Children like Julianna
Ryan Brown, Vice President at Goldman Sachs and Board Member at St. Baldrick’s Foundation, shared…
Dec 29, 2023, 04:56 |
Blog
Rosandra Kaplan: T cell and myeloid populations that contribute to GD2 CART expansion
Rosandra Kaplan, Senior Investigator Physician Scientist Pediatric Oncologist at National Cancer Institute (NCI), on LinkedIn:…
Nov 16, 2023, 18:05 |
Blog
Uta Dirksen: Verena Körber has been awarded the Kind Philipp Prize 2022 at the GPOH meeting
Uta Dirksen, Vice Director Pediatrics III at Universität Duisburg-Essen, University Hospital, made the following post…
Oct 16, 2023, 13:58 |
Blog
Would you like to participate in a multicenter, randomized trial where you will use virtual reality goggles for planning your neuroblastoma surgeries?
Neuroblastoma is one of the most common solid tumors in pediatric patients and its surgical…
Oct 15, 2023, 17:30 |
Blog
Maite Gorostegui: Great Neuroblastoma FPS at SIOP2023
Maite Gorostegui, Pediatric Oncologist at Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, and…
Oct 12, 2023, 18:12 |
Stories
St. Baldrick's Foundation: This 4th grader is happy to be a “regular" kid - her wish for all kids with cancer.
Quoting St. Baldrick's Foundation on LinkedIn: "Ten-year-old Isabella loves to dance. When she isn’t in…
Oct 6, 2023, 16:09 |
Blog
Giselle Sholler: The FDA-ODAC said YES to DFMO!!
Quoting Giselle Sholler, Division Chief Pediatric Hematology, Oncology, BMT at Penn State Health Children's Hospital,…
Sep 25, 2023, 15:22 |
Blog
Michelle Mitchell: These findings from a study funded by Cancer Research UK (CRUK) mean we can be optimistic that treatment of neuroblastoma in the future will be kinder on children with this type of cancer, and improve their quality of life.
Jul 4, 2023, 17:24 |
Blog
Did you ever wonder what RNA rings, so called circular RNAs have to do with neuroblastoma - Steffen Fuchs
Did you ever wonder what RNA rings, so called circular RNAs (circRNAs) have to do…
All:
42
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube